Evidence map›Paper›PMID 21637377›Full record

ArticleJournal of signal transduction2011

Integrins are the necessary links to hypertrophic growth in cardiomyocytes.

Rebecca K Harston, Dhandapani Kuppuswamy

Open access · hybridAbstract read
In one paragraph

Article in Journal of signal transduction, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Extracellular matrix-mediated cellular communication in the heart.Journal of molecular and cellular cardiology · 2016
    Review
  13. Review
  14. Talin1 is required for cardiac Z-disk stabilization and endothelial integrity in zebrafish.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2015
    Article
  15. The (dys)functional extracellular matrix.Biochimica et biophysica acta · 2015
    Review
  16. Article
  17. Article
  18. Mechanosensing and Regulation of Cardiac Function.Journal of clinical & experimental cardiology · 2014
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rebecca K HarstonCardiology Division, Department of Medicine, Gazes Cardiac Research Institute, Medical University of South Carolina, Charleston, SC 29425-2221, USA.
Dhandapani Kuppuswamy
Medical University of South Carolina · US

Funding

TRAINING TO IMPROVE CARDIOVASCULAR THERAPIEST32HL007260 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MENICK, DONALD R. · 1985 to 2021
$11.1M
mTOR in Growth and Protection of Hypertrophying MyocardiumR01HL092124 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KUPPUSWAMY, DHANDAPANI · 2009 to 2012
$1.5M
NHLBI NIH HHS R01 HL092124NHLBI NIH HHS T32 HL007260
6 · The paper itself

Abstract

To compensate for hemodynamic overload of the heart, an event which stretches the myocardium, growth and survival signaling are activated in cardiac muscle cells (cardiomyocytes). Integrins serve as the signaling receptors of cardiomyocytes responsible for mechanotransduction toward intracellular signaling. The main integrin heterodimers on the cardiomyocyte surface are α(5)β(1) and α(v)β(3), and elimination of either β(1) or β(3) integrins impedes pressure-induced hypertrophic signaling and leads to increased mortality. The growth signaling pathways downstream of β(1) and β(3) integrins are well characterized. However, new integrin pathways responsible for inhibiting apoptosis induced by hemodynamic overload are emerging. β(1) and β(3) integrins activate differential survival signaling, yet both integrins initiate survival signaling downstream of ubiquitination and the kinase pathway including phosphoinositol-3-kinase (PI3K)/Akt. Further characterization of these integrin-signaling mechanisms may lead to drug targets to prevent decompensation to heart failure.

Identifiers

PMID21637377
PMCPMC3101892
OpenAlexW1973030441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.